Moolec Science SA (MLEC) Revenue & Revenue Breakdown
Moolec Science SA Revenue Highlights
Latest Revenue (Y)
$905.05K
Latest Revenue (Q)
$252.11K
Moolec Science SA Revenue by Period
Moolec Science SA Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $905.05K | 100.00% |
| 2022-06-30 | - | - |
Moolec Science SA generated $905.05K in revenue during NA 2022, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Moolec Science SA Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $252.11K | -85.51% |
| 2023-09-30 | $1.74M | 92.26% |
| 2023-06-30 | $905.05K | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | - |
Moolec Science SA generated $252.11K in revenue during Q2 2023, up -85.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Moolec Science SA Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JANX | Janux Therapeutics | $8.08M | $8.90M |
| CNTA | Centessa Pharmaceuticals | $6.88M | - |
| GBIO | Generation Bio | $5.90M | $4.09M |
| IPSC | Century Therapeutics | $2.23M | $791.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| MLEC | Moolec Science SA | $905.05K | $252.11K |
| LYEL | Lyell Immunopharma | $130.00K | $34.00K |
| RZLT | Rezolute | - | - |
| GPCR | Structure Therapeutics | - | - |
| FBRX | Forte Biosciences | - | - |
| CVKD | Cadrenal Therapeutics | - | - |
| TPST | Tempest Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| NVCT | Nuvectis Pharma | - | - |
| INDP | Indaptus Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $727.00K |